Cargando…
The immune landscape of solid pediatric tumors
BACKGROUND: Large immunogenomic analyses have demonstrated the prognostic role of the functional orientation of the tumor microenvironment in adult solid tumors, this variable has been poorly explored in the pediatric counterpart. METHODS: We performed a systematic analysis of public RNAseq data (TA...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188257/ https://www.ncbi.nlm.nih.gov/pubmed/35690832 http://dx.doi.org/10.1186/s13046-022-02397-z |
_version_ | 1784725334786048000 |
---|---|
author | Sherif, Shimaa Roelands, Jessica Mifsud, William Ahmed, Eiman I. Raynaud, Christophe M. Rinchai, Darawan Sathappan, Abbirami Maaz, Ata Saleh, Ayman Ozer, Erdener Fakhro, Khalid A. Mifsud, Borbala Thorsson, Vésteinn Bedognetti, Davide Hendrickx, Wouter R. L. |
author_facet | Sherif, Shimaa Roelands, Jessica Mifsud, William Ahmed, Eiman I. Raynaud, Christophe M. Rinchai, Darawan Sathappan, Abbirami Maaz, Ata Saleh, Ayman Ozer, Erdener Fakhro, Khalid A. Mifsud, Borbala Thorsson, Vésteinn Bedognetti, Davide Hendrickx, Wouter R. L. |
author_sort | Sherif, Shimaa |
collection | PubMed |
description | BACKGROUND: Large immunogenomic analyses have demonstrated the prognostic role of the functional orientation of the tumor microenvironment in adult solid tumors, this variable has been poorly explored in the pediatric counterpart. METHODS: We performed a systematic analysis of public RNAseq data (TARGET) for five pediatric tumor types (408 patients): Wilms tumor (WLM), neuroblastoma (NBL), osteosarcoma (OS), clear cell sarcoma of the kidney (CCSK) and rhabdoid tumor of the kidney (RT). We assessed the performance of the Immunologic Constant of Rejection (ICR), which captures an active Th1/cytotoxic response. We also performed gene set enrichment analysis (ssGSEA) and clustered more than 100 well characterized immune traits to define immune subtypes and compared their outcome. RESULTS: A higher ICR score was associated with better survival in OS and high risk NBL without MYCN amplification but with poorer survival in WLM. Clustering of immune traits revealed the same five principal modules previously described in adult tumors (TCGA). These modules divided pediatric patients into six immune subtypes (S1-S6) with distinct survival outcomes. The S2 cluster showed the best overall survival, characterized by low enrichment of the wound healing signature, high Th1, and low Th2 infiltration, while the reverse was observed in S4. Upregulation of the WNT/Beta-catenin pathway was associated with unfavorable outcomes and decreased T-cell infiltration in OS. CONCLUSIONS: We demonstrated that extracranial pediatric tumors could be classified according to their immune disposition, unveiling similarities with adults’ tumors. Immunological parameters might be explored to refine diagnostic and prognostic biomarkers and to identify potential immune-responsive tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-022-02397-z. |
format | Online Article Text |
id | pubmed-9188257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91882572022-06-12 The immune landscape of solid pediatric tumors Sherif, Shimaa Roelands, Jessica Mifsud, William Ahmed, Eiman I. Raynaud, Christophe M. Rinchai, Darawan Sathappan, Abbirami Maaz, Ata Saleh, Ayman Ozer, Erdener Fakhro, Khalid A. Mifsud, Borbala Thorsson, Vésteinn Bedognetti, Davide Hendrickx, Wouter R. L. J Exp Clin Cancer Res Research BACKGROUND: Large immunogenomic analyses have demonstrated the prognostic role of the functional orientation of the tumor microenvironment in adult solid tumors, this variable has been poorly explored in the pediatric counterpart. METHODS: We performed a systematic analysis of public RNAseq data (TARGET) for five pediatric tumor types (408 patients): Wilms tumor (WLM), neuroblastoma (NBL), osteosarcoma (OS), clear cell sarcoma of the kidney (CCSK) and rhabdoid tumor of the kidney (RT). We assessed the performance of the Immunologic Constant of Rejection (ICR), which captures an active Th1/cytotoxic response. We also performed gene set enrichment analysis (ssGSEA) and clustered more than 100 well characterized immune traits to define immune subtypes and compared their outcome. RESULTS: A higher ICR score was associated with better survival in OS and high risk NBL without MYCN amplification but with poorer survival in WLM. Clustering of immune traits revealed the same five principal modules previously described in adult tumors (TCGA). These modules divided pediatric patients into six immune subtypes (S1-S6) with distinct survival outcomes. The S2 cluster showed the best overall survival, characterized by low enrichment of the wound healing signature, high Th1, and low Th2 infiltration, while the reverse was observed in S4. Upregulation of the WNT/Beta-catenin pathway was associated with unfavorable outcomes and decreased T-cell infiltration in OS. CONCLUSIONS: We demonstrated that extracranial pediatric tumors could be classified according to their immune disposition, unveiling similarities with adults’ tumors. Immunological parameters might be explored to refine diagnostic and prognostic biomarkers and to identify potential immune-responsive tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-022-02397-z. BioMed Central 2022-06-11 /pmc/articles/PMC9188257/ /pubmed/35690832 http://dx.doi.org/10.1186/s13046-022-02397-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Sherif, Shimaa Roelands, Jessica Mifsud, William Ahmed, Eiman I. Raynaud, Christophe M. Rinchai, Darawan Sathappan, Abbirami Maaz, Ata Saleh, Ayman Ozer, Erdener Fakhro, Khalid A. Mifsud, Borbala Thorsson, Vésteinn Bedognetti, Davide Hendrickx, Wouter R. L. The immune landscape of solid pediatric tumors |
title | The immune landscape of solid pediatric tumors |
title_full | The immune landscape of solid pediatric tumors |
title_fullStr | The immune landscape of solid pediatric tumors |
title_full_unstemmed | The immune landscape of solid pediatric tumors |
title_short | The immune landscape of solid pediatric tumors |
title_sort | immune landscape of solid pediatric tumors |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188257/ https://www.ncbi.nlm.nih.gov/pubmed/35690832 http://dx.doi.org/10.1186/s13046-022-02397-z |
work_keys_str_mv | AT sherifshimaa theimmunelandscapeofsolidpediatrictumors AT roelandsjessica theimmunelandscapeofsolidpediatrictumors AT mifsudwilliam theimmunelandscapeofsolidpediatrictumors AT ahmedeimani theimmunelandscapeofsolidpediatrictumors AT raynaudchristophem theimmunelandscapeofsolidpediatrictumors AT rinchaidarawan theimmunelandscapeofsolidpediatrictumors AT sathappanabbirami theimmunelandscapeofsolidpediatrictumors AT maazata theimmunelandscapeofsolidpediatrictumors AT salehayman theimmunelandscapeofsolidpediatrictumors AT ozererdener theimmunelandscapeofsolidpediatrictumors AT fakhrokhalida theimmunelandscapeofsolidpediatrictumors AT mifsudborbala theimmunelandscapeofsolidpediatrictumors AT thorssonvesteinn theimmunelandscapeofsolidpediatrictumors AT bedognettidavide theimmunelandscapeofsolidpediatrictumors AT hendrickxwouterrl theimmunelandscapeofsolidpediatrictumors AT sherifshimaa immunelandscapeofsolidpediatrictumors AT roelandsjessica immunelandscapeofsolidpediatrictumors AT mifsudwilliam immunelandscapeofsolidpediatrictumors AT ahmedeimani immunelandscapeofsolidpediatrictumors AT raynaudchristophem immunelandscapeofsolidpediatrictumors AT rinchaidarawan immunelandscapeofsolidpediatrictumors AT sathappanabbirami immunelandscapeofsolidpediatrictumors AT maazata immunelandscapeofsolidpediatrictumors AT salehayman immunelandscapeofsolidpediatrictumors AT ozererdener immunelandscapeofsolidpediatrictumors AT fakhrokhalida immunelandscapeofsolidpediatrictumors AT mifsudborbala immunelandscapeofsolidpediatrictumors AT thorssonvesteinn immunelandscapeofsolidpediatrictumors AT bedognettidavide immunelandscapeofsolidpediatrictumors AT hendrickxwouterrl immunelandscapeofsolidpediatrictumors |